Michael Klipper, a formulary chemist, entrepreneur, author, and fundraiser is the Co-Founder of Cannabinoid Science International Corp. (CSI), which functions as a scientific accelerator/incubator for Cannabis related research, development, and commercialization. It's was established to develop precision made Cannabinoid based formulary compounds that can be manufactured world-wide and made available to individuals in need of healing. By collaborating with leading researchers in Biochemistry, Physics, Computer Science (systems biology), and Healthcare Services; CSI is committed to developing scientifically proven treatments, educating regulatory agencies, healthcare professionals, and patients. This will essentially improve quality of life and health outcomes, while championing a paradigm shift in society well being. Michael is a respected member of the International Cannabinoid Research Society (ICRS).
Michael is also championing scientific research for healing with non-Cannabis therapies. Michael is Director of Business Development for Transforming Medicine (www.transformingmedicine.org), as well as a Founding Board Member of Voices Against Brain Cancer (www.voicesagainstbraincancer.org) (VABC), a 501(c)(3) committed to finding a cure for brain cancer and brain tumors by advancing scientific research and supporting patients, their families and caregivers afflicted with this devastating disease. Since its inception, Michael has held an active role on VABC's Granting Committee and has forged relationships with the leading neuro oncologists, surgeons, and researchers. In 2009, his role expanded to that of Chairman of VABC where under his leadership, millions have been raised to fund scientific research and support programs for the brain cancer community. Michael continues efforts in pioneering brain cancer treatments.
Michael was President & CEO of The Klipper Group, 1996-2013, a family of companies actively involved in formulary chemistry, developing chemical compounds, processes, and metering delivery devices. Under his leadership, the Klipper Group received the prestigious Champion Award from the United States Environmental Protection Agency (EPA), highest recognition, for developing Safer Detergents for The Environment. Michael is the co-author of Textile Laundering Technology, a publication recognized as the "bible" for the textile process industry. He was selected by Dr. Lynn Sehulster, Center for Disease Control, for "peer review" of revised "Guidelines for Environmental Infection Control in Health-Care Facilities" published by the CDC (2005). He was also the Principal Investigator in research establishing new process protocols for low temperature chlorine oxidation. Michael is the inventor of BIOZYME enzyme product and process, the Co-inventor of MICRO-OUNCE fluid and metering technology, and the inventor of COOLTERGENT 120, a commercial laundry detergent developed to successfully remove heavily soiled textiles at 120°F. Michael is a Graduate of Farleigh Dickenson University.